⌘K

Login Start Free

Home/Filings/4/0001610618-24-000152

4//SEC Filing

Mineo Chrysa 4

Accession 0001610618-24-000152

CIK 0001610618other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 6:18 PM ET

Size

5.4 KB

Accession

0001610618-24-000152

Insider Transaction Report

Form 4

Period: 2024-12-17

Cidara Therapeutics, Inc.CDTX

Director

Transactions

Award
Stock Option (right to buy)
2024-12-17+19,000→ 19,000 total
Exercise: $22.81Exp: 2034-12-16→ Common Stock (19,000 underlying)

Footnotes (1)

[F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of December 17, 2024.

Documents

1 file

4
wk-form4_1734650303.xmlPrimary
FORM 4

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1

filerCIK 0001575644

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 6:18 PM ET
Size: 5.4 KB

View on SEC.gov